Abstract
A total of 150 patients were included in the analysis. Through chart review, we estimated glomerular filtration rate in the first visit and, at least, 5 years later. All patients were divided into two groups: (1) metaphylaxis adherents (n = 74) and (2) metaphylaxis non-adherents (n = 76). We followed all patients for at least 5 years. The Scr percentage of patients and GFR <60 mL/min was compared between groups. Variables were compared between groups using t test, χ2 tests, odds ratios with 95% confidence intervals. There were no differences at baseline between groups. After 5 years of follow-up, GFR was 77.9 mL/min in non-adherent-metaphylaxis group and in the adherent-metaphylaxis group was 87.3 mL/min, with p value of 0.02. After 5 years of follow-up, we had a GFR <60 mL/min in the adherent-metaphylaxis group (4.89 vs. 21.95%) with p value of 0.001 and OR = 5.36; IC-95% = 1.95–14.8. Metaphylaxis of kidney stone disease could prevent chronic kidney disease.
Similar content being viewed by others
References
Curhan GC (2007) Epidemiology of stone disease. Urol Clin North Am 34(3):287–293
Romro V, Akpinar H, Assinos DG (2010) Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol 12(2–3):e86–e96
Lieske JC, Peja de la Vega LS, Slezak JM, Bergstralh EJ, Leibson CL, Ho KL, Gettman MT (2006) Renal stone epidemiology in Rochester, Minnesota: an update. Kidney Int 69(4):760–764
Stamatelou KK, Francis ME, Jones CA et al (2003) Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63:1817–1823
Frymoyer PA, Scheinman SJ, Dunhan DB, Jones DB, Hueben P, Schoroeder ET (1991) X-linked recessive nephrolithiasis with renal failure. N Engl J Med 325(10):681–686
Leumann EP (1985) Primary hyperoxaluria: an important cause of renal failure in infancy. Int J Pediatr Nephrol 6(1):13–16
De Walter R, Noordermeer C, Nizze H, Schröder FH, Kok DJ (1999) Calcium oxalate nephrolithiasis: the significance of monocytes and macrophages. In: Borghi L, Meschi T, Briganti A, Schianchi T, Novarini (eds) Kidney stones, proceedings of the European symposium on urolithiasis, Parma, Italy, editoriale bios, pp 329–333
Toblli EJ, Romano L, Nyberg C, Angerosa M, Pagano P, Ferder L, Inserra F (1996) Renal tubulointersticial (TI) protection in hyperoxaluric (Hox) rats. J Am Soc Nephrol 6:1748A (abstract)
Holmes MS, Lieske JC, Pawar S, Spargo BH, Toback FG (1995) Calcium oxalate monohydrate crystals stimulate gene expression in renal epithelial cells. Kidney Int 48:501–509
Koul H, Kennington L, Honeyman T, Jonassenn J, Menon M, Scheid C (1996) Activation of c-myc gene expression in renal epithelial cells in LLC-PK1 cell, a line of renal epithelial cells. Kidney Int 50:1525–1530
Lieske JC, Hammes MS, Hoyer JR, Toback G (1997) Renal cell osteopontin production is stimulated by calcium oxalate monohydrate crystals. Kidney Int 51:679–686
Koten JW, Van Gastel C, Dorhoutmees EJ, Holleman LWJ, Schuiling RD (1965) Two cases of primary oxalosis. J Clin Pathol 18:223–229
Lieske JC, Spargo BH, Toback G (1992) Endocytosis of calcium oxalate crystals and proliferation of renal tubular epithelial cells in a with type 1 primary hyperoxaluria. J Urol 148:1517–1519
Goswami A, Singhal PC, Wagner JD, Urivetky M, Valderrama E, Smith AD (1995) Matrix modulates uptake of calcium oxalate crystals and cell growth of renal epithelial cells. J Urol 153:206–211
Lieske JC, Toback FG (1996) Interaction of urinary crystals with renal epithelial cells en the pathogenesis of nephrolithiasis. Semin Nephrol 16:458–473
Scheid CR, Koul H, Hill WA, Luber-Narod J, Kenington L, Honeyman T, Jonassen J, Menon M (1996) Oxalate toxicity in LLC-PK1 cells: role of free radicals. Kidney Int 49:413–419
Hosking DH, Erickson SB, Van den Berg CJ, Wilson DM, Smith LH (1983) The stone clinic effect in patients with idiopathic calcium urolithiasis. J Urol 130(6):1115–1118
Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, Novarini A (2002) Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 346(2):77–84
Ettinger B, Citron JT, Livermore B, Dolman LI (1988) Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. J Urol 139(4):679–684
Nijenhuis T, Hoenderop JG, Loffing J, van der Kemp AW, van Os CH, Bindels RJ (2003) Thiazide-induced hypocalciuria is accompanied by a decreased expression of Ca2+ transport proteins in kidney. Kidney Int 64(2):555–564
Ettinger B, Tang A, Citron JT, Livermore B, Williams T (1986) Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med 315(22):1386–1389
Favus MJ, Coe FL (1980) The effects of allopurinol treatment on stone formation on hyperuricosuric calcium oxalate stone-formers. Scand J Urol Nephrol Suppl 53:265–271
Barcelo P, Wuhl O, Servitge E, Rousaud A, Pak CY (1993) Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol 150(6):1761–1764
Coe FL, Parks JH, Asplin JR (1992) The pathogenesis and treatment of kidney stones. N Engl J Med 327(16):1141–1152
Vupputuri S, Soucie M, Mcclellan W, Sandler DP (2004) History of kidney stones as a possible factor for chronic kidney disease. AEP 14(3):222–228
Jungers P, Joly D, Barbey F, Choukroun G, Daudon M (2004) ESRD caused by nephrolithiasis: prevalence, mechanisms, and prevention. Am J Kidney Dis 44(5):799–805
Pyrah LN (1979) Renal calculus. Springer, Berlin, pp 27–28
Larssom PA, Cano M, Grenabo L, Brorson J-E, Hederlin H, Petersson S, Johansson SL (1989) Morphological lesions or rat urinary tract pathogens. Urol Int 44:210–217
Braude AI, Siemenski I (1960) Role of bacterial urease in experimental pyelonephritis. J Bacteriol 80:171–179
Mac Laren DM, Peerbooms PGH (1986) Urinary infection by urea splitting microorganism. In: Asscher AW, Brumfitt W (eds) Microbial diseases in nephrology. Wiley, New York
Koga S, Arakaki Y, Matsuoka M, Ohyma C (1991) Staghorn calculi: long term results of management. Br J Urol 68:122–124
Igarashi T, Hayakawa H, Shiraga H, Kawato H, Yan K, Kawaguchi H, Yamanaka T, Tsuchida S, Akagi K (1995) Hypercalciuria and nephrocalcinosis in patients with idiopathic low-molecular-weight proteinuria in Japan: is disease identical to Dent’s disease in United Kingdom. Nephron 69:242–247
Khan SR (2010) Nephrocalcinosis in animal models with and without stones. Urol Res 38(6):429–438
Sakhaee K (2008) Nephrolithiasis as a systemic disorder. Curr Opin Nephrol Hypertens 17:304–309
Evan AP, Coe FL, Lingeman JE, Worcester E (2005) Insights on the pathology of kidney stone formation. Urol Res 33(5):333–389
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Meneses, J.A., Lucas, F.M., Assunção, F.C. et al. The impact of metaphylaxis of kidney stone disease in the renal function at long term in active kidney stone formers patients. Urol Res 40, 225–229 (2012). https://doi.org/10.1007/s00240-011-0407-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00240-011-0407-5